Stevens-Johnson Syndrome Canada

Virtual Town Hall

10 Years Celebration

August 25, 2022

Center for Drug Safety & Immunology Seminar Series

Mary Carrington, PhD

Effect of HLA-I Signal Peptide Variation on HLA-E Expression and NK Cell Function
January 9, 2023

Mona Mashayekhi, MD, PhD

The Effects of Anti-Diabetes on Innflammation in Obesity
October 24, 2022

David M. Patrick, MD, PhD

The Immunoproteasome: A Critical Mediator of Immune Activation in Arterial Hypertension
September 26, 2022

Nathaniel Bloodworth, MD, PhD

Identifying Immunogenic Neoantigens in Hypertension
September 19, 2022

Margaret L. Axelrod, PhD

Cytotoxic T cells Specific for Alpha-Myosin Drive Immunotherapy Related Myocarditis
August 15, 2022

Andrea Raye Shiakolas, PhD

Antibody Discovery via LIBRA-seq: Linking B cell Receptor to Antigen Specificity Through Screening
April 25, 2022

Paul Norman, PhD

Co-evolutioon of Polymorphic Immune Genes Across Human Populations
April 11, 2022

Jonathan A. Kropski, MD

Epithelial Repair and Remodeling at Single-Cell Resolution
March 21, 2022

Jeffrey C. Rathmell, PhD

Fueling T Cells and Immunometabolism in T cell-Mediated Inflammation
March 7, 2022

Posters from the American Academy of Allergy, Asthma, and Immunology (AAAAI) Meeting

Phoenix, AZ   -   February 25 - 28, 2022

Grace Koo, MD
A Two-Year Experience DelabelIng Low-Risk Penicillin Allergy in the Critical Care setting: Benefits OBSERVED for the Most Vulnerable

Jessica Plager, MD
Already on the Treatment: A CASE of IgE-Mediated Insulin Hypersensitivity

Andrew Gibson, PhD

Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage.

10 For TEN

Louis Chaix - Rollerblade Across America - June, 2022